Caitlin Raymond: Practicing at the Edge of ABO – Navigating Rare A Subgroups
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”I just published a new post on Blood, Bytes, and Beyond: “Practicing at the Edge of ABO: Navigating Rare A Subgroups.”
In transfusion medicine, we talk a lot about “weak A” phenotypes — but biologically and clinically, they’re not all the same.
A3, Aw, and Ael arise through different mechanisms, carry different degrees of antigen expression, and sit in very different evidence spaces when it comes to transfusion risk.
This piece grew out of a real on-service case, where the literature didn’t quite tell us what to do, and judgment mattered as much as data.
It’s a reflection on how we make conservative decisions when incidence data are sparse, case reports loom large, and the downside of being wrong is asymmetric.
If you work in transfusion medicine, blood banking, or laboratory medicine more broadly — or if you’re interested in how clinicians navigate uncertainty at the bedside — I’d love for you to read it.”
Read the full post here.
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda